12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
周三盘后交易时段，12只医疗保健类股走势
Gainers
获胜者
- Bone Biologics (NASDAQ:BBLG) stock moved upwards by 56.0% to $0.81 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 2.3 million shares, which is 878.8 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $2.5 million. The company's, Q3 earnings came out yesterday.
- Exagen (NASDAQ:XGN) stock rose 15.78% to $1.76. The market value of their outstanding shares is at $29.6 million. As per the press release, Q3 earnings came out 2 days ago.
- PAVmed (NASDAQ:PAVM) shares increased by 11.31% to $0.25. The company's market cap stands at $27.4 million. As per the news, the Q3 earnings report came out yesterday.
- GRI Bio (NASDAQ:GRI) shares rose 9.9% to $1.22. The market value of their outstanding shares is at $3.6 million.
- Surrozen (NASDAQ:SRZN) shares rose 6.2% to $0.4. The company's market cap stands at $12.3 million.
- Heart Test Laboratories (NASDAQ:HSCS) shares increased by 6.0% to $0.16. Trading volume for this security closed at 31.8 million, accounting for 1722.0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.7 million.
- 在周三的盘后交易中，Bone Biologics（纳斯达克股票代码：BBLG）股价上涨56.0％，至0.81美元。该证券今天的交易量最终收于230万股，占其过去100天平均交易量的878.8％。他们流通股的市值为250万美元。该公司昨天公布了第三季度的收益。
- Exagen（纳斯达克股票代码：XGN）股价上涨15.78％，至1.76美元。他们流通股的市值为2960万美元。根据新闻稿，第三季度财报是在两天前发布的。
- PavMed（纳斯达克股票代码：PAVM）股价上涨11.31％，至0.25美元。该公司的市值为2740万美元。根据消息，第三季度收益报告于昨天发布。
- GRI Bio（纳斯达克股票代码：GRI）股价上涨9.9％，至1.22美元。他们流通股的市值为360万美元。
- Surrozen（纳斯达克股票代码：SRZN）股价上涨6.2％，至0.4美元。该公司的市值为1,230万美元。
- 心脏测试实验室（纳斯达克股票代码：HSCS）股价上涨6.0％，至0.16美元。该证券的交易量收于3180万，占其过去100天平均全日交易量的1722.0％。该公司的市值为170万美元。
Losers
失败者
- Augmedix (NASDAQ:AUGX) shares decreased by 20.8% to $4.3 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 66.5K shares, which is 29.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $175.4 million.
- Impel Pharmaceuticals (NASDAQ:IMPL) shares declined by 15.94% to $0.24. The market value of their outstanding shares is at $5.5 million.
- OpGen (NASDAQ:OPGN) stock declined by 9.34% to $0.44. The company's market cap stands at $4.7 million. As per the press release, Q3 earnings came out yesterday.
- Autolus Therapeutics (NASDAQ:AUTL) shares declined by 9.2% to $3.85. The market value of their outstanding shares is at $669.8 million.
- Baudax Bio (NASDAQ:BXRX) stock decreased by 8.66% to $0.17. The market value of their outstanding shares is at $1.5 million.
- Cocrystal Pharma (NASDAQ:COCP) shares fell 8.29% to $1.66. The company's market cap stands at $16.8 million. As per the news, the Q3 earnings report came out 2 days ago. See Also:
- 在周三的盘后交易中，Augmedix（纳斯达克股票代码：AUGX）股价下跌20.8％，至4.3美元。该证券今天的交易量最终收于66.5万股，占其过去100天平均交易量的29.6％。他们流通股的市值为1.754亿美元。
- 英佩尔制药（纳斯达克股票代码：IMPL）股价下跌15.94％，至0.24美元。他们流通股的市值为550万美元。
- OpGen（纳斯达克股票代码：OPGN）股价下跌9.34％，至0.44美元。该公司的市值为470万美元。根据新闻稿，第三季度财报于昨天公布。
- Autolus Therapeutics（纳斯达克股票代码：AUTL）股价下跌9.2％，至3.85美元。他们流通股的市值为6.698亿美元。
- Baudax Bio（纳斯达克股票代码：BXRX）股价下跌8.66％，至0.17美元。他们流通股的市值为150万美元。
- Cocrystal Pharma（纳斯达克股票代码：COCP）股价下跌8.29％，至1.66美元。该公司的市值为1,680万美元。根据消息，第三季度收益报告是在2天前发布的。另见：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。